Targeting CD33 for acute myeloid leukemia therapy

BACKGROUND: The aim of this study was to analyze the level of CD33 expression in patients with newly diagnosed AML and determine its correlation with clinical characteristics. METHODS: Samples were collected for analysis from AML patients at diagnosis. We evaluated the level of CD33 expression by fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingjing, Tong, Jiayin, Yang, Haiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722076/
https://www.ncbi.nlm.nih.gov/pubmed/34980040
http://dx.doi.org/10.1186/s12885-021-09116-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722076/
https://www.ncbi.nlm.nih.gov/pubmed/34980040
http://dx.doi.org/10.1186/s12885-021-09116-5

Ejemplares similares